The Food and Drug Administration has delayed a promised review of safety data for the abortion drug mifepristone at Commissioner Marty Makary’s request to put it off until after the midterm elections,

Two state lawmakers are sparring over how to enshrine protections in state law for women who have miscarriages or other pregnancy complications

A top anti-abortion activist called for the leader of the Food and Drug Administration to be fired on Tuesday after reports indicated that he is putting off a long-awaited safety review of the abortion pill mifepristone until after the 2026 midterm elections.

The ballot measure also includes a ban on gender affirming health care for minors. Judges reissued the summary statement that voters will see on November 2026 ballots to make clear rights were being repealed,